Obesity Fueling Narcolepsy Market Growth Driver: Leading Transformation in the Narcolepsy Market in 2025

What Are the Projected Growth and Market Size Trends for the Narcolepsy Market?
The narcolepsy market has experienced swift expansion over the past few years. The market is projected to increase from $3.56 billion in 2024 to $3.99 billion in 2025, correspondingly reflecting a compound annual growth rate (CAGR) of 12.0%. The significant growth observed during the historic period is due to several factors, including heightened awareness regarding narcolepsy, advancements and enhancements in diagnostic instruments, the initiation of novel pharmacological treatments, investments in research and development, and improved efforts in patient education.

Rapid expansion is anticipated for the narcolepsy market size in the coming years, with a predicted growth to $6.21 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. This growth, forecasted for the coming period, is due to the increased prevalence of sleep disorders, enhanced healthcare facilities, supportive governmental policies, a growing aging population, and an increasing awareness of health among consumers. The upcoming period will witness trends like advancements in genetic studies, advancements in diagnostic technology, launch of new drug and treatment methods, strategic alliances and partnerships among major market players, and the use of digital health tools and telemedicine.

What Are the Primary Growth Drivers for the Narcolepsy Market?
The increasing prevalence of obesity is anticipated to spur the expansion of the narcolepsy market in the future. Obesity, characterized by an excessive build-up of body fat that poses a threat to health, is on the rise due to sedentary lifestyles, poor eating habits, and environmental factors that encourage consumption of calorie-rich food and decrease physical activity. This condition can lead to narcolepsy by creating an imbalance in metabolic and hormone levels, possible alterations in sleep patterns, and wakefulness regulation. As per the World Health Organization, a distinguished United Nations agency based in Switzerland in charge of global public health, nearly 1 billion individuals including 650 million adults, 340 million teenagers, and 39 million children were considered obese as of March 2022, and the number continues to grow. Estimates suggest that by 2025, roughly 167 million adults and children will be dealing with health issues related to overweight. Hence, the rise in obesity figures is fuelling the development of the narcolepsy market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp

Which Leading Companies Are Shaping the Growth of the Narcolepsy Market?
Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Ono Pharmaceutical Co. Ltd, Lupin Pharmaceuticals, Alkermes, Harmony Biosciences, Arena Pharmaceuticals, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Suven Life Sciences Ltd

What Are the Major Trends Shaping the Narcolepsy Market?
Firms at the forefront of the narcolepsy market, such as Avadel Pharmaceuticals plc based in Ireland, are ramping up their efforts to innovate new medicines like extended-release sodium oxybate, responding to the heightened need for efficient remedies. Serving as a narcolepsy solution, the extended-release variation of sodium oxybate is engineered for steady distribution of the medication over a prolonged duration. This results in persistent relief from symptoms all through the night, thereby enhancing sleep quality for narcolepsy patients. To illustrate this trend, Avadel Pharmaceuticals introduced LUMRYZ in the US market in June 2023. As an FDA-approved extended-release version of sodium oxybate, LUMRYZ is designed to treat cataplexy or excessive daytime sleepiness (EDS) in adults who are narcoleptic. Standing alone as the inaugural once-per-night oxybate treatment for narcolepsy, it marks a substantial progress over twice-per-night oxybate products, eliminating the requirement for patients to disrupt their sleep for a secondary dosage.

What Are the Key Segments of the Narcolepsy Market?
The narcolepsy market covered in this report is segmented -

1) By Type: Type 1, Type 2
2) By Treatment: Antidepressants, Stimulants, Sodium Oxybate, Other Treatments
3) By Diagnosis: Polysomnogram, Multiple Sleep Latency Test
4) By End Users: Hospitals, Retail Pharmacies, Other End Users

Subsegments:
1) By Type 1: Stimulant Medications, Antidepressants, Sodium Oxybate, Immunosuppressive Treatments
2) By Type 2: Stimulant Medications, Sodium Oxybate, Antidepressants

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Which Region Dominates the Narcolepsy Market?
North America was the largest region in the narcolepsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Narcolepsy Global Market Report?

- Market Size Analysis: Analyze the Narcolepsy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Narcolepsy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Narcolepsy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Narcolepsy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16491

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.